Diffuse Large B-cell Lymphoma

Addressing Disparities in Care for Patients with DLBCL
Addressing Disparities in Care for Patients with DLBCL
CME, CPE
James O. Armitage, MD; and Loretta J. Nastoupil, MD
Release Date: September 21, 2022
Expiration Date: September 21, 2023

Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma. In this activity, two experts discuss disparities in care for patients with DLBCL. They will address topics such as barriers in care, participation in clinical trials, and improved treatment landscape. This activity will conclude with a discussion on tools to use for best practice.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Bristol Myers Squibb and Genentech, a member of the Roche Group.
Begin, Earn CreditView Only, No Credit
 

© 2022 MediCom Worldwide, Inc. All rights reserved